Discovery Could Lead to New Therapies for Diabetics

News   Jan 12, 2018 | Original story by Mount Desert Island Biological Laboratory

 
Discovery Could Lead to New Therapies for Diabetics

New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes. Credit: MDI Biological Laboratory

 
 
 

RELATED ARTICLES

Hay Fever Risk Genes Overlap with Autoimmune Disease

News

In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.

READ MORE

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

Olfactory Receptors Not Just For Smell Perception

News

Novel cellular functions of olfactory receptors highlighted

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy